Needle-free Vaccines Lead Intercell to the US with its Latest Acquisition
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 96 (Table of Contents)
Published: 13 May-2008
DOI: 10.3833/pdr.v2008.i96.182 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Intercell has turned to the US to acquire Iomai - a company that will expand its travellers vaccine franchise and deliver novel transcutaneous immunization technology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS